These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37927864)

  • 1. Risk of loss to follow-up among tuberculosis patients in South Korea: whom should we focus on?
    Kim HW; Min J; Ko Y; Oh JY; Jeong YJ; Lee EH; Yang B; Koo HK; Lee SS; Park JS; Park KJ; Chang JH; Joh J; Lee MK; Kim JS
    Front Public Health; 2023; 11():1247772. PubMed ID: 37927864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    Yu S; Sohn H; Kim HY; Kim H; Oh KH; Kim HJ; Chung H; Choi H
    PLoS Med; 2021 Jul; 18(7):e1003717. PubMed ID: 34260579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Unfavorable Outcomes of Tuberculosis in Korea: Implications for Patient-Centered Care in Tuberculosis Treatment.
    Hong HY; Park Y; Yong SH; Woo A; Leem AY; Lee SH; Chung KS; Lee SH; Kim SY; Kim EY; Jung JY; Park MS; Kim YS; Shin SJ; Kang YA
    J Korean Med Sci; 2024 Jan; 39(2):e4. PubMed ID: 38225780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea.
    Kim HW; Park S; Min J; Sun J; Shin AY; Ha JH; Park JS; Lee SS; Lipman M; Abubakar I; Stagg HR; Kim JS
    Sci Rep; 2022 Jul; 12(1):12362. PubMed ID: 35859107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of loss to follow-up among adult tuberculosis patients in Southern Ethiopia: a retrospective follow-up study.
    Watumo D; Mengesha MM; Gobena T; Gebremichael MA; Jerene D
    BMC Public Health; 2022 May; 22(1):976. PubMed ID: 35568853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
    Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
    BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study.
    Kim HW; Min J; Shin AY; Koo HK; Lim SY; Park MJ; Park YB; Lee J; Lee SS; Park JS; Kim JS
    Int J Tuberc Lung Dis; 2020 Oct; 24(10):1016-1023. PubMed ID: 33126933
    [No Abstract]   [Full Text] [Related]  

  • 10. Retreatment after loss to follow-up reduces mortality in patients with multidrug/rifampicin-resistant tuberculosis.
    Choi H; Mok J; Ae Kang Y; Jeong D; Kang HY; Kim HJ; Kim HS; Jeon D
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37583964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with unfavourable treatment outcomes in people with HIV-associated tuberculosis in Armenia, 2015 to 2019.
    Gevorgyan L; Grigoryan R; Dumchev K; Akopyan K; Khachatryan A; Kabasakalyan E; Grigoryan T; Safaryan M; Avagyan V; Hasanova S; Matteelli A
    Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profiles of early and tuberculosis-related mortality in South Korea between 2015 and 2017: a cross-sectional study.
    Min J; Kim JS; Kim HW; Shin AY; Koo HK; Lee SS; Kim YK; Shin KC; Chang JH; Chun G; Lee J; Park MS; Park JS
    BMC Infect Dis; 2019 Aug; 19(1):735. PubMed ID: 31438876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
    Bassett IV; Chetty S; Wang B; Mazibuko M; Giddy J; Lu Z; Walensky RP; Freedberg KA; Losina E
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):25-30. PubMed ID: 22027877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low BMI increases all-cause mortality rates in patients with drug-resistant TB.
    Adamashvili N; Baliashvili D; Kuchukhidze G; Salindri AD; Kempker RR; Blumberg HM; Lomtadze N; Avaliani Z; Magee MJ
    Int J Tuberc Lung Dis; 2022 Apr; 26(4):326-333. PubMed ID: 35351237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
    Yende-Zuma N; Naidoo K
    J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study.
    Adamashvili N; Akopyan K; Tukvadze N; Dumchev K; Sereda Y; Khonelidze I; Kuchukhidze G
    Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liberia adherence and loss-to-follow-up in HIV and AIDS care and treatment: A retrospective cohort of adolescents and adults from 2016-2019.
    Gray KL; Kiazolu M; Jones J; Konstantinova A; Zawolo JSW; Gray WH; Walker NF; Garbo JT; Caldwell S; Odo M; Bhadelia N; DeMarco J; Skrip LA
    PLOS Glob Public Health; 2022; 2(3):e0000198. PubMed ID: 36962289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes Status and Association With Risk of Tuberculosis Among Korean Adults.
    Yoo JE; Kim D; Han K; Rhee SY; Shin DW; Lee H
    JAMA Netw Open; 2021 Sep; 4(9):e2126099. PubMed ID: 34546370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors of serious adverse events during antituberculous treatment in Rwanda: a prospective cohort study.
    Lorent N; Sebatunzi O; Mukeshimana G; Van den Ende J; Clerinx J
    PLoS One; 2011; 6(5):e19566. PubMed ID: 21611117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.